11 10 16 Categories:
Media Release | MedicalBody Positive is thankful to Pharmac for adding
Dolutegravir (Tivicay) to its list of Anti-Retroviral for the treatment of HIV effective November 1st 2016. Dolutegravir is a relatively new drug which was approved by Medsafe in 2014.
Read More...Tags: HIV Treatment, Living with HIV
16 08 16 Categories:
MedicalA community-based sexual health clinic in San Francisco has offered nurse-led pre-exposure prophylaxis (PrEP) services to more than 1200 clients and has seen no HIV infections to date, according to a presentation last month at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa.
Read More...Tags: Study, PrEP, Treatment as Prevention
16 08 16 Categories:
MedicalParticipants in the START treatment-timing trial who took antiretroviral regimens containing efavirenz had an increased risk of suicidal and self-injuring behaviour than those not using efavirenz, though the number of events was small and the effect was mainly seen among people with a prior psychiatric diagnosis, according to research presented at the 21st International AIDS Conference (AIDS 2016) last month in Durban, South Africa.
Read More...Tags: Study, HIV Treatment, Living with HIV
21 07 16 Categories:
MedicalOdds of seeing a transmission now even lower, but more data still needed on gay men, say researchersThe PARTNER study, which two years ago created headlines by establishing that the chance of an HIV-positive person with an undetectable viral load transmitting their virus was very low and quite possibly zero, released new data at the 21st International AIDS Conference (AIDS 2016) that further refined this estimate.
Read More...Tags: Study, HIV Transmission, Treatment as Prevention
19 01 16 Categories:
GeneralA global team of medical researchers from NZ and the UK are developing a transformative health app to help support positive health changes in people living with HIV.
Between January and September 2016, researchers will recruit PLHIV to participate in an online survey. User feedback pooled from the survey will help the research team understand key issues faced by PLHIV so they can be integrated into the final app design. There’s no obligation, but all interested parties affected by HIV who wish to contribute to the app design can register at
www.mpowr.life/project Read More...Tags: Study